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Summary Photodynamic therapy (PDT) may cause tumour cell destruction by direct toxicity or by inducing cellular hypoxia as a result of
microcirculatory shutdown. Aminolaevulinic acid (ALA) causes cellular accumulation of protoporphyrin IX (PPIX) in cells exposed to it in
excess. PPIX can be used as a photosensitizer for PDT. Microcirculatory shutdown may be induced by toxicity to the endothelial and vascular
smooth muscle (VSM) cells or by release of vasoactive substances. We have studied whether PPIX is produced by endothelial, VSM and
tumour cells on exposure to ALA and whether these cell lines are directly damaged by PDT in vitro. Tumour endothelial cells are angiogenic
and we have, therefore, investigated the effect of cellular proliferation rates on PPIX generation. Tumour cells generate more PPIX
intracellularly than the non-neoplastic cell lines studied and are correspondingly more sensitive to PDT-induced cytotoxicity. Endothelial cells
are sensitive to PDT-induced cytotoxicity and accumulate between 1.5 and four times more PPIX when proliferating (as during tumour-
induced angiogenesis) than when quiescent. We conclude that PPIX-mediated PDT may exert some of its effects on the microcirculation of
treated tissues by direct toxicity to enothelial and VSM cells, and that this toxicity may be enhanced in the tumour microenvironment.
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Photodynamic therapy (PDT) is a treatment for cancer based on
the photosensitization of tumour cells and their subsequent
destruction on exposure to light. Aminolaevulinic acid (ALA) is a
precursor for the cellular biosynthesis of haem. There are two rate-
limiting steps in this process: synthesis of ALA from succinyl
CoA and glycine by the enzyme ALA synthetase and conversion
of protoporphyrin IX (PPIX) to haem by the enzyme
ferrochelatase (Martin et al, 1983). Provision of cells with excess
exogenous ALA bypasses the first rate-limiting step causing accu-
mulation of PPIX, a photosensitizer that can be used in PDT. On
exposure to light, reactive oxygen species are produced (van
Steveninck et al, 1986; Weishaupt et al, 1989), causing cellular
damage and ultimately cell death. This damage may be direct or
may result from hypoxia induced by shutdown of the tissue micro-
circulation. Microcirculatory shutdown has been shown to occur
following PDT in vivo with both traditional porphyrin photosensi-
tizers (Reed et al, 1989a) and, more recently, ALA-induced PDT
(Roberts et al, 1994; Leveckis et al, 1995).
The mechanism of microcirculatory shutdown induced by PDT
is poorly understood. It may be caused by a direct PDT-induced
cytotoxicity to the endothelial and vascular smooth muscle cells
or by PDT-induced release of vasoactive substances such as
prostaglandins (Reed et al, 1989b; Lindberg et al, 1994) or the
impaired release of vasodilators such as nitric oxide (Gilissen et al,
1993). PDT also has effects on mast cells (Yen et al, 1990), which
release the vasoactive substance histamine. Direct cytotoxicity to
the microcirculation will only occur if the endothelial and vascular
smooth muscle cells produce PPIX on exposure to ALA. At
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present, there is conflicting evidence as to whether this occurs. In
vivo fluorescence microscopy studies of the cellular distribution of
PPIX have shown accumulation by tumour cells, but little in
stromal cells (fibroblasts, endothelial cells and smooth muscle
cells) (Loh et al, 1993). Bedwell et al (1992) found no fluores-
cence in endothelial cells, although more recently Roberts et al
(1994) demonstrated fluorescence in the lining cells of tumour
microvascular spaces. In vitro, human umbilical vein endothelial
cells (HUVECs) have been shown to accumulate PPIX on expo-
sure to ALA (Lim et al, 1994), but microvascular endothelial cells
(MVECs) have not been studied.
Cellular sensitivity to PDT-induced toxicity is known to be
influenced by a number of factors. These include the oxygenation
of the cell (Mitchell et al, 1984), the tolerance of the cell to free
radicals, which is enhanced if excess ferric iron is present (Lin and
Girotti, 1995), and the intracellular concentration of PPIX (linuma
et al, 1994), which depends on the balance between the rate of
PPIX synthesis and its removal by cellular efflux and conversion
to haem.
The rate of PPIX accumulation is enhanced by cellular iron
depletion (linuma et al, 1994; Lim et al, 1994; Rittenhouse-Diakun
et al, 1995) and a rapid cellular proliferation rate (Rebeiz et al,
1992; Schick et al, 1995). It may be influenced by the phase of the
cell cycle, the cellular availability of oxygen (Falk et al, 1959) and
the pH of the extracellular fluid, which may influence ALA uptake
by the cell (Bermudez-Moretti et al, 1993). It has also been
demonstrated that certain neoplastic cells have reduced activity of
the enzyme ferrochelatase (Shoenfeld et al, 1988; El-Sharabasy et
al, 1992). The efflux of PPIX from a cell is thought to be an active
process and may be dependent on the extracellular concentration
of serum (Hanania and Malik, 1992; Fukuda et al, 1993) or, more
specifically, albumin (Steinbach et al, 1995). All of these factors
may be altered in the tumour microenvironment, where there is an
excess of tumour-derived angiogenic factors, local areas of
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hypoxia and acidosis and cellular nutrient depletion (Vaupel et al,
1989). Endothelial cells are usually quiescent in normal tissues,
but are stimulated to proliferate in the presence of tumour-derived
growth factors, and they may therefore respond differently to PDT
under these circumstances. The aims of this study are: (1) to inves-
tigate whether there is production and accumulation of PPIX by
vascular endothelial and smooth muscle cells on exposure to ALA
and whether this leads to a direct PDT-induced toxicity; (2) to
compare the rate of PPIX accumulation between different cell
lines; and (3) to study the effect of changes in proliferation rates
that may influence PPIX accumulation and PDT sensitivity in the
tumour microenvironment. The influence of proliferation rate on
PPIX accumulation was studied at different phases of cell growth.
Proliferation rate changes were also induced by altering the
concentration of serum present in the culture media, since serum
contains growth factors that stimulate cellular proliferation.
MATERIALS AND METHODS
Cell lines
Human umbilical vein endothelial cells (HUVECs) were extracted
from human umbilical cords by digestion with type IV collagenase
according to the method of Jaffe et al (1973). Human micro-
vascular endothelial cells (MVECs) were extracted from human
adipose tissue by type II collagenase digestion and subsequent
endothelial cell selection with anti-platelet endothelial cell
adhesion molecule (PECAM)-1 monoclonal antibody (Beckton
Dickinson)-coated immunomagnetic beads (Dynabeads, Dynal,
UK) (Hewett and Murray, 1993). Human dermal fibroblasts
(HDFs) were extracted from adult human dermis by type A colla-
genase digestion (Boerhinger Mannheim, UK) and were a kind
gift from S. MacNeal (Department of Medicine, University of
Sheffield, UK). Vascular smooth muscle cells (VSMs) were
obtained from the NIA ageing cell culture repositiory, NJ, USA,
and were a non-immortalized line of bovine aortic origin. MVECs
and HUVECs were fully characterized by endothelium-specific
antibody labelling (Von Willebrand factor and PECAM-1) in this
laboratory. VSM cells were characterized at source by positive
staining for alpha-smooth muscle actin and negative staining
for Von Willebrand factor. Fibroblasts were characterized by
morphology. Human gastric cancer and human bladder cancer cell
lines (AGS and HTl 197) were obtained from the European
Collection of Animal Cell Cultures, Porton Down, UK.
AGS and HT1 197 cells are immortalized tumour cell lines and
were used between passages 77-101 and 14-34 respectively. VSM
and HDF cells were both derived from primary extractions and are
non-immortalized lines. They were used between passages 11-18
and 5-10 respectively. HUVECs and MVECs were both primarily
extracted from their parent tissue in this laboratory and were used
between passages 2-10 and 2-6 respectively. The primarily
extracted cell lines were found to have a reduced proliferative
capacity beyond these limits.
Culture methods
All cell lines were maintained in optimal growth medium
(complete medium) and passaged 1-2 times per week with split
ratios of 4-6 depending on the cell line. HUVECs were grown in
M199 supplemented with 20% fetal calf serum (FCS), penicillin
and streptomycin 1%, Hepes buffer 0.7%, heparin (40 mg 1-l) and
endothelial cell growth supplement (ECGS; First Link, UK).
Flasks were coated with 1% gelatin solution. MVECs were
cultured as above but with the addition of 30% FCS. HDF and
HT1 197 cells were grown in Dulbecco's modified Eagle medium
(DMEM) with the addition of 10% newborn calf serum (NBCS)
and 1% penicillin and streptomgcin. VSM cells were cultured in
DMEM with 10% FCS, penicillin and streptomycin 1% and
sodium pyruvate 1%. AGS cells were cultured in Ham's F12
nutrient medium with 10% FCS and 1% penicillin and strepto-
mycin. For passage, all cells were trypsinized with 0.05% trypsin
and 0.02% EDTA.
The following methods were used to perform the studies
detailed in the experimental protocol.
Cell counting
A sample of 10 gl of the cell suspension was mixed with 90 pl of
0.1% trypan blue. Trypan blue is excluded from viable cells,
whereas non-viable cells with impaired membrane integrity take
up the dye and appear blue on light microscopy (Jacob et al, 1985).
The resultant solution was placed beneath the coverslip of a
Neubauer haemocytometer (Philip Harris Scientific, UK). The
number of viable (unstained) cells was then counted.
PPIX assay
Standard curves PPIX standard (Porphyrin Products, Logan,
UT, USA) was dissolved in a 50:50 mixture of methanol (HPLC
grade) and 0.9M perchloric acid (Fisons, UK). Serial dilution
was performed to obtain a range of concentrations from 0 to
150 ng ml-'. The optical density of these solutions was measured
by spectrofluorimetry (Perkins-Elmer LS-3 fluorescence spectro-
meter) with excitation at 406 nm and emission at 604 nm. The
standard curve produced was used to calculate the PPIX concen-
tration in the test solutions. Similar standard curves were obtained
for PPIX dissolved in the various culture media mixed with an
equal volume of methanol-perchloric acid and centrifuged at
1500 g for 10 min to pellet the protein precipitate (perchloric acid
causes precipitation of protein out of solution). The fluorescence
intensity of the supermatant was then measured.
Test samples Intracellular PPIX. Cell suspensions (in methanol
and perchloric acid, 1:1 ratio) for analysis were homogenized for
5 min at 25 000 r.p.m. with a tissue homogenizer (Ultraturrax;
Janke and Kunkel, Germany). The suspension was centrifuged at
3000 g for 10 min to reduce fluorescence quenching. The super-
natant was analysed spectrofluorimetrically for PPIX. The concen-
tration of PPIX was derived from the optical density of the
solution and the standard curve determined previously. Medium
PPIX. At the end of the incubation period, a sample of the medium
was removed and analysed for PPIX content after first being
mixed with an equal volume of methanol and perchloric acid and
centrifuged at 3000 g to remove the protein precipitate.
Protein assay
A modified Lowry method was used to quantify the amount of
protein in cell homogenates (Lowry et al, 1951). This value was
then used to calculate the amount of PPIX produced per unit of
cellular protein, which allowed standardization for variations
between the number of cells plated into each flask. A commer-
cially available protein assay kit was used (Sigma Chemicals,
UK). Standard solutions of bovine serum albumin were used to
generate a standard curve. Test samples of cell suspensions were
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incubated for 24 h with 0.1 M sodium hydroxide to solubilize the
protein. To 1 ml of each test and standard sample, 0.1 ml of deoxy-
cholic acid was added. Trichloroacetic acid (0.1 ml) was then
added and the sample centrifuged at 3000 g for 10 min to pellet the
protein precipitate. The supernatant was decanted off and the pellet
resuspended in 1 ml of modified Lowry reagent. This was
incubated for 20 min and 0.5 ml of Folin and Ciocalteau's phenol
reagent added. The colour was allowed to develop for 30 min and
the optical density read on a spectrophotometer (Pye Unicam SP8-
100 UV spectrophotometer) at 725 nm. The protein concentration
of the test solutions was calculated from the standard curve.
Cell survival using an MTT assay
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide, is metabolized by a mitochondrial enzyme, lactate
dehydrogenase, to a coloured formazan product (Stratford and
Stephens, 1989). The optical density of the resulting solution is
proportional to the number of viable cells present, which can then
be used to determine cell survival and cytotoxicity.
A sample of 100 g1 of 1 mg ml-' MTT in phosphate-buffered
saline (PBS/A) was added to each well of a 96-well plate after
removal of half (100 gl) of the culture medium. The cells were
incubated for 4 h to allow generation of the coloured formazan
product. The medium was then removed and 200 ,l of dimethyl
sulphoxide (DMSO) was added to each well and mixed by
repeated aspiration with a Gilson pipette. The optical density (OD)
was then read at 550 nm on an enzyme-linked immunosorbent
assay (ELISA) 96-well plate reader (Anthos Labtec Instruments).
Percentage cell survival was calculated from the following
formula:
Percentage cell survival - GD treated well x 100
OD control well
The OD is proportional to the cell number present up to a certain
threshold cell density, above which a plateau is reached. To ensure
that all experiments were performed in the linear range of the
assay, initial standardization assays were carried out. For each cell
line, six wells of a 96-well plate had a known number of cells
added, in the range 5 x 102 to 1 x 106 cells ml-'. Cells were incu-
bated under standard tissue culture conditions for 48 h (humidified
air with 5% carbon dioxide at 37°C). Three of the six wells were
subjected to an MTT assay and three had a cell count performed.
This enabled the initial plating density for each cell line to be
determined for use in subsequent experiments.
Photodynamic therapy
All cells were plated in complete medium into a 96-well plate and
incubated under standard tissue culture conditions for 48 h. The
complete medium was then removed and the cells washed in
PBS/A. Medium, either complete or serum-free, containing 1 mM
ALA was added to each well and the plate incubated for a further
4 h. This medium was removed and replaced with complete
medium. The cells were exposed to violet light (350-460 nm
broad bandpass filter; Leica UK) at 85 mW cm-2 from a mercury
lamp (Leitz, UK). The system was calibrated with an IL 1700 light
meter (International Light). The duration of exposure was varied
to give total light doses of 0.5-30 J cm-2. A thermocouple ther-
mometer (Digisense, Chicago, USA) was used to ensure that no
detectable heating effect occurred during treatment of the cells.
The plates were then returned to the incubator for 24 h and an
MTT assay was then performed. Controls for ALA alone and light
alone (at each light dose) were included for each plate.
Chemicals
The following were obtained from Sigma Chemicals UK: types II
and IV collagenase, gelatin solution 2%, heparin, Hepes buffer,
MTT, DMSO, trypan blue 0.4%, PBS/A and protein assay kit.
The following were obtained from Gibco/Life Technologies, UK:
M199, DMEM, Ham's F12 nutrient medium, NBCS, FCS,
penicillin (10 000 IU ml-1) and streptomycin (10 000 ,ug ml-' and
trypsin/EDTA.
Experimental protocols
Cell doubling and lag times
For all cell types studied, doubling times and lag times were
calculated. Cells were plated at 1 x 103, 5 x 103 and 1 x 104 cells
ml-' into the wells of a 24-well plate. The plates were incubated
under standard tissue culture conditions and at intervals of
initially 24 h and thereafter 48 h, after which cells were
trypsinized and counted. Cell counting was performed on three
wells per day until a plateau was reached (usually after 7-10 days).
The population doubling time (DT) was then estimated at the
midpoint of the exponential phase of the growth curve. The lag
time was defined as the time taken for the cells to exceed their
initial plating density.
Protoporphyrin IX production
This was studied with the cellular proliferation rate modified by
cells in serum-free serum-containing medium, and at various
phases of cell growth, i.e. actively proliferating cells in the expo-
nential phase or quiescent cells in the plateau phase.
Serum-free medium, exponential and plateau growth
phases Each cell line was plated into standard tissue culture
flasks (Costar T 75) in complete medium and incubated for 48 h to
allow cells to enter the exponential phase of their growth curve or
for 7 days to allow the cells to enter the plateau phase. The
complete medium was removed and the cells washed in PBS/A.
A liquots of 10ml of serum-free medium (complete medium
minus serum) with 1 mM ALA were added to each flask and the
cells incubated for either 0, 4 or 24 h. The medium was removed
and analysed for PPIX content. The cells were washed in PBS/A
and trypsinized. The cell suspension was centrifuged at 1500 g for
10 min. The resultant pellet was resuspended in 0.9 M saline, and
half was analysed for protein content and half for PPIX content. At
all stages, the cells were kept in subdued light to minimize
photobleaching of PPIX and photodynamic toxicity.
Complete medium, exponential growth phase The above
protocol was repeated but the ALA was administered to the cells in
complete rather than serum-free medium.
Photodynamic therapy
Sensitivity of cell lines to varying light doses Cells were
plated into 96-well plates and exposed for 4 h to 1 mm ALA in
serum-free medium. Light (0.5, 1, 5, 10 and 30 J cm-2) was
administered to the cells. Controls for light alone and ALA alone
were included. Following a further 24 h incubation, an MTT assay
was performed.
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PDT sensitivity of cells exposed to ALA in serum-free vs
complete medium Cells were plated into 96-well plates and dosed
with 1 mm ALA in either serum-free or complete medium. Light was
administered at the LD50 dose (as determined above), or no light.
After a further 24-h incubation, an MTT assay was performed. The
percentage change in cell numbers between the control groups (no
light, complete medium vs no light, serum-free medium) was then
compared with the percentage change in the treatment groups.
Statistical analyses
Data was analysed using non-parametric tests. Comparison
between multiple groups was by Kruskal-Wallis analysis of vari-
ance and a Mann-Whitney U-test was used to compare between
two groups. Statistical significance was set at P < 0.05.
RESULTS
Characterization of cell lines
The doubling times calculated for the cell lines are shown in
Figure 1. The doubling time of HT1197 was significantly shorter
than that of AGS cells (P < 0.03), which in turn was significantly
less than the MVECs (P < 0.01) and HDF (P < 0.003). HUVECs
grew significantly more slowly than all the other cell lines, with
the exception of MVECs (P < 0.04). All non-immortalized cell
lines had begun their plateau phase by day 7 when plated at 1 x 104
cells ml-l. MVECs and HUVECs strongly contact inhibited after
reaching confluence and assumed a cobblestone morphology, with
a reduced cellular proliferation rate. The VSM and HDF cells were
similarly contact inhibited but continued to proliferate more
slowly forming multiple cell layers. The tumour cell lines, AGS
and HT1 197, did not demonstrate contact inhibition but did ulti-
mately exhibit a reduced growth rate, probably because of nutrient
depletion or acidosis in the medium. With both tumour cell types,
this plateau was seen at 7 days from plating at the higher plating
densities. For this reason, cells to be studied in the plateau phase of
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Figure 1 Cell doubling times for different cell types
HDF HUVEC
their growth curve were incubated for 7 days after plating at
5 x 104 cells ml-'. Lag times varied between 1 day for VSM cells
and 2.8 days for MVECs (data not shown).
PPIX generation
Serum-free medium, exponential and plateau growth phase
Exponential All of the cell lines studied produce detectable
amounts of PPIX on exposure to ALA. The amount produced
increased with incubation time, but a plateau effect was apparent
by 24 h. Intracellular PPIX levels varied significantly between cell
types after both 4 and 24 h incubation (P < 0.05). Levels were
significantly higher in the neoplastic than in the non-neoplastic cell
lines (Table 1). PPIX efflux into the culture medium also varied
between cell lines. The neoplastic cell lines tended to retain most
of their PPIX intracellularly, with very little being detected in the
medium. The reverse was true of the non-neoplastic cell lines, and
in all cases more PPIX entered the medium than was retained
intracellularly (Table 2). This suggests that, at least in vitro, efflux
rates are an important determinant of PPIX concentration in the
cells. There was no correlation between the proliferation rate of the
cell lines and either the generation or the accumulation of PPIX.
Table 1 Intracellular PPIX concentrations for the different cell types and 4 h and 24 h under different tissue culture conditions
PPIX concentration (intracellular) ng gg-1 cellular protein
Cell type Serum-free medium, Complete medium, Serum-free medium,
exponential growth exponential growth plateau growth
4h 24h 4h 24h 4h 24h
AGS 0.474 1.55 0.14* 0.19* 0.4 2.6 *
(s.e.m.) (0.1) (0.1) (0.01) (0.05) (0.03) (0.38)
HT1197 0.56 1.89 0.14* 0.21 0.37 3.4*
(s.e.m.) (0.1) (0.1) (0.06) (0.03) (0.02) (0.7)
HDF 0.195 0.79 0.08 0.4 0.14 0.56
(s.e.m.) (0.03) (0.08) (0.01) (0.19) (0.01) (0.09)
HUVEC 0.115 0.464 0.029 * 0.05 0.11 0.2
(s.e.m.) (0.03) (0.18) (0.005) (0.003) (0.02) (0.07)
MVEC 0.11 0.819 0.032 * 0.035* 0.05* 0.197*
(s.e.m.) (0.01) (0.29) (0.005) (0.006) (0.006) (0.01)
VSM 0.11 0.057 0.036 * 0.034 0.08 0.12*
(s.e.m.) (0.03) (0.01) (0.01) (0.01) (0.01) (0.03)
Data represent the mean plus the standard error in brackets (n = 4). *P < 0.05 when compared with serum-free, exponential data using Mann-Whitney U-test.
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Table 2 Total (intracellular plus medium) PPIX concentrations for the different cell types at 4 h and 24 h under different tissue culture conditions
PPIX concentration (total) ng ,ug-' cellular protein
Cell type
Serum-free medium, Complete medium, Serum-free medium,
exponential growth exponential growth plateau growth
4h 24h 4h 24h 4h 24h
AGS 0.38 1.57 0.27 1.0* 0.59 3.9*(se.m.) (0.08) (0.03) (0.05) (0.09) (0.14) (0.7)
HT1197 0.49 2.65 0.76 4.6* 0.39 4.2(s.e.m.) (0.09) (0.21) (0.12) (0.54) (0.02) (0.9)
HDF 0.47 1.31 0.24* 1.19 0.24* 1.3(s.e.m.) (0.07) (0.11) (0.01) (0.06) (0.01) (0.16)
HUVEC 1.03 2.0 0.23* 0.37* 0.45 1.3(se.m.) (0.36) (0.22) (0.02) (0.05) (0.11) (0.27)
MVEC 1.2 4.8 0.22* 0.6* 0.45* 0.92*(s.e.m.) (0.26) (0.6) (0.05) (0.14) (0.04) (0.05)
VSM 0.23 0.27 0.14 0.35 0.18 0.41(s.e.m.) (0.04) (0.05) (0.04) (0.08) (0.03) (0.11)
Data represent the mean plus the standard error in brackets (s.e.m.) (n = 4).
Mann-Whitney U-test.
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Figure 2 Showing percentage cell survival following different doses of PDT
after a 4-h incubation with ALA. Data represent the mean with standard
errors. (+) HT1197; (x) AGS; (O) HDF; (O) HUVEC; (A)j MVEC; (E:) VSM
Plateau growth phase
For three of the non-neoplastic cell lines, both the total and the
intracellular PPIX concentration was reduced when cells were in
the plateau phase compared with the exponential phase. This
difference was significant for MVECs and HDF (P < 0.05), was
*P < 0.05 when compared with serum-free, exponential data using
apparent with HUVECs, although not significant, but with VSM
cells no trend was seen. The two neoplastic cell lines demonstrated
the reverse, with significantly more PPIX generated in cells in the
plateau phase. These data are shown in Tables 1 and 2.
Complete medium, exponential growth phase
The cell lines all produced detectable levels of PPIX after incuba-
tion with ALA. However, in all cases the intracellular concentra-
tions of PPIX were significantly reduced (P < 0.05) when
compared with the concentrations produced in serum-free medium
(Table 1), whereas the proportion of PPIX in the medium was
increased. The total amount of PPIX generated (intracellular plus
extracellular) was significantly reduced in complete medium
compared with serum-free medium in four of the cell lines (AGS,
MVECs, HUVECs and HDF; P < 0.05, Table 2). HT1197 cells
showed the reverse, with significantly more PPIX being produced
in complete medium (P < 0.01 at 24 h; Table 2).
PDT-induced cytotoxicity
MTT assay standardization
All the cell types produced significant amounts of formazan after
incubation with MTT for 4 h, with the exception of HT1197,
which required only 2 h to produce high levels. An initial plating
density of 5 x 104 cells ml was found to produce values in the
linear range of the MTT assay calibration curve for all cell types
with the exception of HT1197, which had to be plated at 2.5 x 104
cells ml-'.
All the cell lines were susceptible to PDT-induced cytotoxicity.
The sensitivity varied significantly between cell lines, with the two
neoplastic cell lines being more sensitive than the non-neoplastic
cell lines (Figure 2). The degree of sensitivity demonstrated a good
correlation with the intracellular concentration of PPIX (Table 1).
Controls for light alone showed no significant cytotoxicity with
any of the cell lines. Studies with the thermistor showed that this
light source had no detectable heating effect even at 120 J cm-2.
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Incubation of the cells with ALA alone caused no detectable cyto-
toxicity apart from a small effect with the HT1 197 cells, which
were the most PDT-sensitive cell line.
Effect of serum on PDT-induced cytotoxicity
All the cell lines (with the exception of MVECs) showed a
significant reduction in cell numbers when incubated for 4 h with
serum-free medium compared with serum-containing medium.
This difference was most marked with the three most rapidly
proliferating cell lines. All the cell lines exhibited PDT-induced
cytotoxicity in the complete medium, but the degree of toxicity
was reduced significantly compared with the controls in serum-
free medium (data not shown).
DISCUSSION
This study has demonstrated that both macro- and microvascular
endothelial cells (HUVECs and MVECs) and vascular smooth
muscle cells produce sufficient PPIX after a 4-h incubation with
ALA to be susceptible to PDT-induced toxicity. Four hours is the
usual interval from oral dosing to light exposure in clinical PDT
using ALA. These results are in contrast to in vivo fluorescence
studies, which have suggested that endothelial cells and stromal
cells generally produce little or no PPIX (Bedwell et al, 1992; Loh
et al, 1993). These data therefore suggest that ALA PDT-induced
microcirculatory shutdown may be mediated, in part, by direct
damage to these cells.
We have demonstrated that endothelial cells that are quiescent
(i.e. predominantly in the Go phase of the cell cycle at the plateau
phase of growth) accumulate significantly less PPIX than cells that
are actively proliferating. In normal tissues, endothelial cells have
a very low proliferative activity (Denekamp, 1982). In contrast,
tumour endothelial cells, which are exposed to tumour-derived
angiogenic factors, will be proliferating actively, suggesting that
the tumour microcirculation may be more susceptible to PDT-
induced damage. Thus, the elevated PPIX production by tumour
endothelial cells may enhance microvascular damage in the
tumour tissue, which may increase the efficacy and selectivity of
ALA-induced PDT. This study used two methods to study the
influence of proliferation rates on PPIX production: use of cells in
different phases of their growth curve and use of different serum
concentrations in the medium.
The effect of serum on PPIX production is complex. Addition of
serum to the medium enhances cellular proliferation rates in both
neoplastic and non-neoplastic cell lines. This effect was most
pronounced for the HT1197 cells and least pronounced for the
endothelial cells. Cells that are actively proliferating have a
reduced availability of intracellular iron, as demonstrated by an
increase in their expression of membrance transferrin receptors
(Rittenhouse-Diakun, 1995). This may be because of competition
for iron by enzymes, such as ribonucleotide reductase, which is
necessary for DNA synthesis (Moore and Reichard, 1964). It is
known that low levels of intracellular iron promote the accumula-
tion of PPIX since iron is essential for the activity of the enzyme,
ferrochelatase, which is responsible for the conversion of PPIX to
haem (Martin et al, 1983). Thus, factors that enhance cellular
proliferation rates could result in the generation of increased
cellular PPIX. However, our studies only confirmed this for the
HTl 197, when the addition of serum was used to modify prolifera-
tion rates. The most striking effect of the addition of serum to the
culture medium during ALA treatment of the cells was a significant
reduction in the intracellular concentration of PPIX and a greater
efflux of PPIX into the medium. It is known that PPIX binds to
albumim in the serum (Steinbach et al, 1995), and this will there-
fore enhance the PPIX concentration gradient out of the cell.
However, the total amount of PPIX produced (in the medium and
intracellularly) was reduced in all of the cell lines in the presence of
serum with the exception of HT1197. There are two possible expla-
nations for this anomaly. The HT1 197 cells were the most sensitive
to serum deprivation in terms of a reduction in proliferation rate.
The cells may, therefore, have been subjected to the most increased
availability of intracellular iron as a result. This may have enhanced
ferrochelatase activity and reduced PPIX accumulation by the cell.
The proliferation rates of the other cell lines were not as sensitive to
serum deprivation, so intracellular iron depletion may not have
been so marked. The other possibility is that the transferrin present
in the serum was essential for some of the cell lines to take up
extracellular iron. The absence of transferrin in serum-free medium
provoked intracellular iron depletion (owing to effective extracel-
lular iron deficiency). On the basis of these findings, we suggest
that the modification of the proliferative state of cells by altering
the serum concentration in the medium is not ideal for the study of
porphyrin metabolism in vitro as many other factors are involved
that may confound the effect.
The effect of growth phase on PPIX production was dependent on
whether the cells were neoplastic or non-neoplastic. The non-
neoplastic cell lines, which demonstrated contact inhibition on
reaching confluence, produced less PPIX (both total and intra-
cellular) at plateau than when proliferating rapidly, consistent with
previous observations (Schick et al, 1995). The converse was true
for neoplastic cell lines. These produced more PPIX when confluent
compared with when actively proliferating. These cell lines did not
exhibit contact inhibition, but showed a reduced growth rate when
confluent, with cell layering. This is probably caused by a combina-
tion of nutrient depletion and a build-up of toxic metabolites (such
as lactic acid). It has been shown that ALA is taken up into the cell
by an active transport mechanism that may be pH dependent and is
optimal at a pH of 5.0 (Bermudez Moretti et al, 1993). This greater
uptake of substrate from the more acidic medium may have made
some contribution to the increased PPIX production in neoplastic
cells. Another factor influencing PPIX production may have been
competition for iron from the increased number of cells in the over-
confluent flask, as has been discussed previously.
There are several limitations involved in using cells in different
phases of growth to study the effect of cellular proliferation rates
on PPIX generation. Not all cell lines enter a true plateau phase,
but will continue to increase in number until nutrient depletion
occurs, as has been seen with the cell lines in this study. Another
problem is that certain cell lines will still be undergoing cell divi-
sion, balanced by apoptosis, even in an apparently confluent
monolayer. Depending on the rate of cell turnover, the prolifera-
tion rate of the cells may still be quite high, although it should be
less than in the exponential phase of the growth curve. Finally, the
cell population will be in varying phases of its cell cycle, with a
higher proportion in the Go phase when the cells are confluent.
This may introduce an element of heterogeneity into the experi-
ment, as PPIX accumulation may vary with the phase of its cell
cycle (Fukuda et al, 1993). Such an effect may reduce any differ-
ence in PPIX generation rates. Although these are problems in cell
culture, they may also exist in vivo with variable PPIX production
in the same cell type depending on proliferation rate and cell cycle
phase. Further studies are currently underway in this laboratory to
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investigate the effect of cell cycle phase variation on PPIX genera-
tion rates.
Previous workers have used a variety of methods to alter the
proliferation rates of cells, including various mitogens and a
reduction in the concentration of serum in the culture medium
(Fukuda et al, 1993; Rittenhouse-Diakun et al, 1995; Schick et al,
1995). However, as we have clearly demonstrated in this study,
altering serum concentrations has a more complex effect than
simply changing proliferation rates. Completely removing serum
introduces other factors, such as selective nutrient depletion, and
in the case of some cell lines, the absence of serum-derived growth
factors may trigger programmed cell death. In our experiments, a
progressive fall in the number of cells in the incubation flasks was
noted when serum-free medium was used.
The in vivo situation would differ for the cell lines under study,
with the endothelial cells being exposed to a higher serum concen-
tration than the other cell lines, and in normal tissues these cells
would have a very low proliferative activity. Our data would
suggest that even under such conditions these cells may produce
enough PPIX to suffer PDT-induced cytotoxicity, and that in the
tumour microenvironment, where there are excess angiogenic
growth factors, acidosis and nutrient depletion, their sensitivity to
PDT may be enhanced. The effect on the neoplastic elements of a
tumour would possibly differ in different regions depending on
how well nourished the cells were. Our data would suggest that
such cells would produce more PPIX, but this effect might be
counterbalanced if the cells were in a hypoxic region of the
tumour, since this may reduce the toxicity of PDT and may also
reduce PPIX synthesis (Falk et al, 1959).
This study highlights the complexity of the factors influencing
PPIX generation after ALA administration. When the heteroge-
neous cell population in a tumour is considered, this allows for the
possibility of focal areas of PDT insensitivity when this method of
photosensitization is used. It is this tumour selectivity that makes
ALA-induced PPIX so clinically attractive as a photosensitizer,
but it may limit its effectiveness. However, the effect on the micro-
circulation may improve the treatment efficacy, as cells that are not
directly affected by PDT may succumb to the secondary hypoxia
caused by microcirculatory shutdown. However, the interplay of
the direct and indirect effects of PDT is not yet fully understood.
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